Emily Rogalski to Frontotemporal Dementia
This is a "connection" page, showing publications Emily Rogalski has written about Frontotemporal Dementia.
Connection Strength
4.128
-
Frontotemporal Degeneration with Transactive Response DNA-Binding Protein Type C at the Anterior Temporal Lobe. Ann Neurol. 2023 07; 94(1):1-12.
Score: 0.838
-
The CARE pathway model for dementia: psychosocial and rehabilitative strategies for care in young-onset dementias. Psychiatr Clin North Am. 2015 Jun; 38(2):333-52.
Score: 0.474
-
Behavioural interventions for enhancing life participation in behavioural variant frontotemporal dementia and primary progressive aphasia. Int Rev Psychiatry. 2013 Apr; 25(2):237-45.
Score: 0.414
-
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia. Alzheimers Dement. 2025 Feb; 21(2):e14448.
Score: 0.234
-
Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias. Acta Neuropathol Commun. 2024 Feb 22; 12(1):31.
Score: 0.220
-
Evaluating the association between genetically proxied ACE inhibition and dementias. Alzheimers Dement. 2023 09; 19(9):3894-3901.
Score: 0.207
-
Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C. Brain. 2022 04 29; 145(3):1069-1078.
Score: 0.194
-
Nosology of Primary Progressive Aphasia and the Neuropathology of Language. Adv Exp Med Biol. 2021; 1281:33-49.
Score: 0.177
-
Primary Progressive Aphasia has a Unique Signature Distinct from Dementia of the Alzheimer's Type and Behavioral Variant Frontotemporal Dementia Regardless of Pathology. J Neuropathol Exp Neurol. 2020 12 04; 79(12):1379-1381.
Score: 0.176
-
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. Alzheimers Dement. 2020 01; 16(1):37-48.
Score: 0.166
-
Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement. 2020 01; 16(1):118-130.
Score: 0.165
-
Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21.
Score: 0.165
-
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020 02; 19(2):145-156.
Score: 0.164
-
Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes. Acta Neuropathol. 2019 07; 138(1):167-169.
Score: 0.158
-
Genetic screen in a large series of patients with primary progressive aphasia. Alzheimers Dement. 2019 04; 15(4):553-560.
Score: 0.155
-
Combined Pathologies in FTLD-TDP Types A and C. J Neuropathol Exp Neurol. 2018 05 01; 77(5):405-412.
Score: 0.147
-
Atrophy and microglial distribution in primary progressive aphasia with transactive response DNA-binding protein-43 kDa. Ann Neurol. 2018 06; 83(6):1096-1104.
Score: 0.037
-
A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain. 2017 Apr 01; 140(4):1128-1146.
Score: 0.034